Violetta Squadrito

Messina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Update on leukodystrophies and developing trials.

Update on leukodystrophies and developing trials.

Journal: Journal of neurology

Published: July 17, 2023

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study.

Journal: Frontiers in pediatrics

Published: February 20, 2023

Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis.

Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis.

Journal: Frontiers in pharmacology

Published: October 18, 2022

Appropriateness of Antibiotic Prescribing in Hospitalized Children: A Focus on the Real-World Scenario of the Different Paediatric Subspecialties.

Appropriateness of Antibiotic Prescribing in Hospitalized Children: A Focus on the Real-World Scenario of the Different Paediatric Subspecialties.

Journal: Frontiers in pharmacology

Published: March 05, 2022

Photodynamic therapy in pediatric age: Current applications and future trends.

Photodynamic therapy in pediatric age: Current applications and future trends.

Journal: Frontiers in pharmacology

Published: February 19, 2022

Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?

Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?

Journal: Frontiers in pharmacology

Published: February 19, 2022

MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells.

MAO-A Inhibition by Metaxalone Reverts IL-1β-Induced Inflammatory Phenotype in Microglial Cells.

Journal: International journal of molecular sciences

Published: July 07, 2021

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity.

Targeting Adenosine Receptor by Polydeoxyribonucleotide: An Effective Therapeutic Strategy to Induce White-to-Brown Adipose Differentiation and to Curb Obesity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 03, 2021

PDRN, a natural bioactive compound, blunts inflammation and positively reprograms healing genes in an "in vitro" model of oral mucositis.

PDRN, a natural bioactive compound, blunts inflammation and positively reprograms healing genes in an "in vitro" model of oral mucositis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 27, 2021

A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily.

A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily.

Journal: Frontiers in pharmacology

Published: April 30, 2020

Nutraceutical Effects of Lycopene in Experimental Varicocele: An "In Vivo" Model to Study Male Infertility.

Nutraceutical Effects of Lycopene in Experimental Varicocele: An "In Vivo" Model to Study Male Infertility.

Journal: Nutrients

Published: March 24, 2020

PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.

PDRN, a Bioactive Natural Compound, Ameliorates Imiquimod-Induced Psoriasis through NF-κB Pathway Inhibition and Wnt/β-Catenin Signaling Modulation.

Journal: International journal of molecular sciences

Published: January 08, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026